Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-Part, Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

NCT07404306 is registered in ClinicalTrials.gov with Haisco-USA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT07404306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07404306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-Part, Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users
Lead sponsor
Haisco-USA Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 16, 2022
Completion date
October 3, 2023
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

general anesthesia